A new research project aims to shed light on what happens to the brain as young people mature, as part of a £5.4 million project funded by the Wellcome Trust.
The Wellcome Trust, in conjunction with the Massachusetts Institute of Technology (MIT), is offering opportunities for early-career researchers to carry out interdisciplinary research at MIT.
The Wellcome Trust has awarded a £5 million Seeding Drug Discovery award to GlaxoSmithKline plc (GSK) to support its open approach to discovering and developing urgently needed new treatments for diseases of low-income countries.
The Wellcome Trust has joined with the Public Library of Science and Google to launch the Accelerating Science Award Program (ASAP) to recognise the use of scientific research, published through open access, that has led to innovations in any field that benefit society.
Resistance to the frontline antimalarial drug, artemisinin, can be identified and tracked by analysing the genetic fingerprint of parasite populations, a study published online today in ‘Nature Genetics’ demonstrates.
Researchers have uncovered details of a mechanism that bacteria use to avoid the effects of antibiotics, which could pave the way for developing new drugs to counteract antibiotic resistance.
An experimental antibiotic for Clostridium difficile infections developed with support from the Wellcome Trust has successfully completed a phase I clinical trial and is well tolerated by healthy volunteers.
A study, led by researchers at the Wellcome Trust Sanger Institute, highlights the importance of zebrafish as a model organism for human disease research.
Epigenesis, a computer game developed by Dead Shark Triplepunch from Blekinge Institute of Technology in Sweden, has won Make Something Unreal Live 2013, the European student game development competition.
The Wellcome Trust launches its latest portfolio review, 'Population and Public Health, 1990–2011', which describes the key breakthroughs in the field over the past two decades and the Trust's role during this time.
Dr Shahid Jameel has been appointed CEO of the India Alliance, an £80 million partnership between the Wellcome Trust and the Department of Biotechnology, Government of India.
More than 80 regions of the genome that can increase an individual's risk of breast, prostate and ovarian cancers have been found in the largest ever study of its kind.